FDA Adverse Event Injury Summary report: N

SYNCHROMED II

MDR report key: 7710462 · Received July 23, 2018

Report

Report Number
3004209178-2018-16381
Event Type
Injury
Date Received
July 23, 2018
Date of Event
June 28, 2018
Report Date
October 5, 2018
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID 8781 LOT# (B)(4). IMPLANTED: (B)(6) 2018, EXPLANTED: (B)(6) 2018. PRODUCT TYPE CATHETER. MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS" OR HAS "MALFUNCTIONED". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

ADDITIONAL INFORMATION WAS RECEIVED. IT WAS REPORTED THAT THE DATE THAT THE PUMP AND CATHETER WERE INITIALLY IMPLANTED WAS (B)(6) 2018. IT WAS REPORTED THAT THE CSF COLLECTION WAS FIRST NOTICED DAY 2 TO 3 POST-OP. IT WAS REPORTED THAT THE CATHETER WAS RE-CONNECTED IN THE 1ST EXPLORATION AND THEN THE CATHETER WAS REPLACED IN THE 2ND RE-EXPLORATION. IT WAS REPORTED THAT ANY CONTRIBUTING FACTORS THAT LED TO THE EVENT WAS THAT THE PATIENT WAS A SMOKER AND MAYBE THE COUGH WAS A RISK FACTOR. IT WAS REPORTED THAT THE PATIENT'S SPASTICITY WAS NOT IMPROVED AFTER THE 1ST SURGERY. THE SPASTICITY IMPROVED PARTIALLY AFTER THE 1ST-EXPLORATION AND RE-CONNECTION (2ND SURGERY, 10 DAYS POST-OP). THE SPASTICITY ONLY IM PROVED COMPLETELY AFTER THEY REPLACED THE CONNECTION WITH NEW CATHETER (3RD SURGERY, 3 WEEKS POST-OP). IT WAS REPORTED THAT ONLY REPLACED THE TIP OF THE PUMP SEGMENT WAS REPLACED AND THAT THEY USED A NEW CONNECTER TO CONNECT WITH THE INTRATHECAL ALREADY PLACED CATHETER, SO THE INTRADURAL PART WAS NOT CHANGED OR MODIFIED. IT WAS REPORTED THAT THE PUMP SEGMENT WAS REPLACED WITH THE NEW ON MONDAY (B)(6) 2018. IT WAS REPORTED THAT THE REPLACED PUMP SEGMENT WAS THROWN AWAY AND THUS WILL NOT BE RETURNED. NO FURTHER COMPLICATIONS WERE REPORTED AND/OR ANTICIPATED.

Additional Manufacturer Narrative · 1

PRODUCT ID (B)(4) LOT# 0215044218 SERIAL# IMPLANTED: (B)(6) 2018 EXPLANTED: (B)(6) 2018 PRODUCT TYPE CATHETER. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

THE MAIN COMPONENT OF THE SYSTEM. OTHER RELEVANT DEVICE(S) ARE: PRODUCT ID: 8781, SERIAL/LOT #: (B)(4), UBD: (B)(6) 2020, UDI#: (B)(4). (B)(6). IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

(B)(4). IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

PRODUCT ID 8781, LOT# 0215044218, IMPLANTED: (B)(6) 2018, EXPLANTED: (B)(6) 2018. PRODUCT TYPE CATHETER. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

INFORMATION WAS RECEIVED FROM A FOREIGN HEALTHCARE PROFESSIONAL (HCP) VIA A MANUFACTURER REPRESENTATIVE REGARDING A PATIENT WHO WAS RECEIVING AN UNKNOWN DRUG WITH AN UNKNOWN CONCENTRATION AND UNKNOWN DAILY DOSE VIA AN IMPLANTABLE PUMP FOR AN UNKNOWN INDICATION FOR US. IT WAS REPORTED THAT THE PATIENT WAS ADMITTED ON (B)(6) 2018 FOR CATHETER REVISION SURGERY DUE TO CEREBROSPINAL FLUID (CSF) COLLECTION IN THE PUMP POCKET SIDE THERE WAS CLEAR CSF BACK FLOW COMING FROM THE PUMP SEGMENT AND AROUND THE PUMP TUBE. IT WAS REPORTED THAT DURING THE REVISION THE CONNECTION BETWEEN THE PUMP SEGMENT AND THE PUMP WAS A BIT LOOSE AND THE LEAKAGE OF CSF WAS FROM THAT SIDE. THE DOCTOR TRIED DOING VALSALVA MANEUVER WITH 40 MPH FOR 5 SECOND AND WE HAVE A CLEAR CSF BACK FLOW COMING FROM PUMP SEGMENT AND AROUND THE PUMP TUBE. AFTER CONNECTING THE CATHETER TIP AGAIN TO THE PUMP AND HEARING A CLEAR ¿TICK¿ SOUND, THE DOCTOR ASKED THE ANESTHESIA TECHNICIAN TO APPLY VALSALVA AT 40 MPH FOR 10 SECONDS TO THE PATIENT, AT THIS STAGE WE DIDN'T WITNESS ANY LEAK OF CSF. NO FURTHER COMPLICATIONS WERE REPORTED AND/OR ANTICIPATED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED. IT WAS REPORTED THAT THERE WERE NO ISSUES NOTED WITH THE TIP SEGMENT THAT COULD HAVE LED TO OR CONTRIBUTED TO THE PATIENT'S SPASTICITY. IT WAS REPORTED THAT THERE WERE NO OTHER LIKELY CAUSES OR CONTRIBUTING FACTORS TO THE PATIENT'S SPASTICITY. NO FURTHER COMPLICATIONS WERE REPORTED AND/OR ANTICIPATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
552016 SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION 8637-20

Patients

Seq Age Sex Outcome Treatment
1 30 YR Required Intervention